nodes	percent_of_prediction	percent_of_DWPC	metapath
Zileuton—UGT1A9—Mycophenolic acid—systemic scleroderma	0.35	0.465	CbGbCtD
Zileuton—UGT1A9—Mycophenolate mofetil—systemic scleroderma	0.195	0.26	CbGbCtD
Zileuton—CYP1A2—Pentoxifylline—systemic scleroderma	0.0615	0.0817	CbGbCtD
Zileuton—CYP1A2—Leflunomide—systemic scleroderma	0.0586	0.078	CbGbCtD
Zileuton—CYP2C9—Leflunomide—systemic scleroderma	0.0528	0.0703	CbGbCtD
Zileuton—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.019	0.0252	CbGbCtD
Zileuton—CYP2C9—cardial valve—systemic scleroderma	0.0171	0.319	CbGeAlD
Zileuton—CYP3A4—Prednisone—systemic scleroderma	0.0152	0.0202	CbGbCtD
Zileuton—LTB4R—skin of body—systemic scleroderma	0.00477	0.0891	CbGeAlD
Zileuton—LTB4R—lung—systemic scleroderma	0.00319	0.0595	CbGeAlD
Zileuton—EPHX2—tendon—systemic scleroderma	0.00267	0.0499	CbGeAlD
Zileuton—UGT1A9—digestive system—systemic scleroderma	0.00257	0.0479	CbGeAlD
Zileuton—EPHX2—lung—systemic scleroderma	0.00235	0.0438	CbGeAlD
Zileuton—PTGS1—artery—systemic scleroderma	0.00234	0.0437	CbGeAlD
Zileuton—ALOX5—connective tissue—systemic scleroderma	0.00233	0.0435	CbGeAlD
Zileuton—ALOX5—smooth muscle tissue—systemic scleroderma	0.00213	0.0398	CbGeAlD
Zileuton—PTGS1—endothelium—systemic scleroderma	0.00198	0.0369	CbGeAlD
Zileuton—PTGS1—blood vessel—systemic scleroderma	0.00182	0.034	CbGeAlD
Zileuton—ALOX5—digestive system—systemic scleroderma	0.00168	0.0314	CbGeAlD
Zileuton—ALOX5—lung—systemic scleroderma	0.00141	0.0262	CbGeAlD
Zileuton—PTGS1—connective tissue—systemic scleroderma	0.000935	0.0175	CbGeAlD
Zileuton—PTGS1—smooth muscle tissue—systemic scleroderma	0.000856	0.016	CbGeAlD
Zileuton—PTGS1—skin of body—systemic scleroderma	0.000845	0.0158	CbGeAlD
Zileuton—Jaundice—Leflunomide—systemic scleroderma	0.00083	0.00427	CcSEcCtD
Zileuton—Urinary tract infection—Leflunomide—systemic scleroderma	0.000828	0.00425	CcSEcCtD
Zileuton—Conjunctivitis—Leflunomide—systemic scleroderma	0.000828	0.00425	CcSEcCtD
Zileuton—Sinusitis—Leflunomide—systemic scleroderma	0.000799	0.00411	CcSEcCtD
Zileuton—Tension—Captopril—systemic scleroderma	0.000792	0.00407	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Pentoxifylline—systemic scleroderma	0.000792	0.00407	CcSEcCtD
Zileuton—Jaundice—Mycophenolic acid—systemic scleroderma	0.000792	0.00407	CcSEcCtD
Zileuton—Urinary tract infection—Mycophenolic acid—systemic scleroderma	0.000789	0.00406	CcSEcCtD
Zileuton—Conjunctivitis—Mycophenolic acid—systemic scleroderma	0.000789	0.00406	CcSEcCtD
Zileuton—Insomnia—Pentoxifylline—systemic scleroderma	0.000786	0.00404	CcSEcCtD
Zileuton—Nervousness—Captopril—systemic scleroderma	0.000784	0.00403	CcSEcCtD
Zileuton—Chest pain—Mometasone—systemic scleroderma	0.000782	0.00402	CcSEcCtD
Zileuton—Arthralgia—Mometasone—systemic scleroderma	0.000782	0.00402	CcSEcCtD
Zileuton—Myalgia—Mometasone—systemic scleroderma	0.000782	0.00402	CcSEcCtD
Zileuton—CYP1A2—digestive system—systemic scleroderma	0.00078	0.0145	CbGeAlD
Zileuton—Somnolence—Pentoxifylline—systemic scleroderma	0.000773	0.00397	CcSEcCtD
Zileuton—Dyspepsia—Pentoxifylline—systemic scleroderma	0.000765	0.00393	CcSEcCtD
Zileuton—Hepatitis—Leflunomide—systemic scleroderma	0.000764	0.00393	CcSEcCtD
Zileuton—Upper respiratory tract infection—Lisinopril—systemic scleroderma	0.000763	0.00392	CcSEcCtD
Zileuton—Sinusitis—Mycophenolic acid—systemic scleroderma	0.000762	0.00392	CcSEcCtD
Zileuton—Ill-defined disorder—Captopril—systemic scleroderma	0.000749	0.00385	CcSEcCtD
Zileuton—Constipation—Pentoxifylline—systemic scleroderma	0.000743	0.00382	CcSEcCtD
Zileuton—CYP2C9—digestive system—systemic scleroderma	0.00074	0.0138	CbGeAlD
Zileuton—Hepatitis—Mycophenolic acid—systemic scleroderma	0.000729	0.00375	CcSEcCtD
Zileuton—Malaise—Captopril—systemic scleroderma	0.000728	0.00374	CcSEcCtD
Zileuton—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.000716	0.00368	CcSEcCtD
Zileuton—Hyperbilirubinaemia—Methotrexate—systemic scleroderma	0.000714	0.00367	CcSEcCtD
Zileuton—Jaundice—Lisinopril—systemic scleroderma	0.000713	0.00367	CcSEcCtD
Zileuton—Urinary tract infection—Lisinopril—systemic scleroderma	0.000711	0.00366	CcSEcCtD
Zileuton—Urticaria—Pentoxifylline—systemic scleroderma	0.000691	0.00355	CcSEcCtD
Zileuton—Chest pain—Captopril—systemic scleroderma	0.000687	0.00353	CcSEcCtD
Zileuton—Arthralgia—Captopril—systemic scleroderma	0.000687	0.00353	CcSEcCtD
Zileuton—Myalgia—Captopril—systemic scleroderma	0.000687	0.00353	CcSEcCtD
Zileuton—Body temperature increased—Pentoxifylline—systemic scleroderma	0.000687	0.00353	CcSEcCtD
Zileuton—Sinusitis—Lisinopril—systemic scleroderma	0.000686	0.00353	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.000683	0.00351	CcSEcCtD
Zileuton—Discomfort—Captopril—systemic scleroderma	0.000679	0.00349	CcSEcCtD
Zileuton—PTGS1—digestive system—systemic scleroderma	0.000676	0.0126	CbGeAlD
Zileuton—Dyspepsia—Mometasone—systemic scleroderma	0.00066	0.00339	CcSEcCtD
Zileuton—Hepatitis—Lisinopril—systemic scleroderma	0.000657	0.00338	CcSEcCtD
Zileuton—Flatulence—Leflunomide—systemic scleroderma	0.000656	0.00337	CcSEcCtD
Zileuton—Ill-defined disorder—Azathioprine—systemic scleroderma	0.000654	0.00336	CcSEcCtD
Zileuton—CYP1A2—lung—systemic scleroderma	0.000651	0.0121	CbGeAlD
Zileuton—Vaginal inflammation—Methotrexate—systemic scleroderma	0.000649	0.00334	CcSEcCtD
Zileuton—PTGS1—tendon—systemic scleroderma	0.000643	0.012	CbGeAlD
Zileuton—Pain—Mometasone—systemic scleroderma	0.000641	0.0033	CcSEcCtD
Zileuton—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00064	0.00329	CcSEcCtD
Zileuton—Malaise—Azathioprine—systemic scleroderma	0.000635	0.00327	CcSEcCtD
Zileuton—Flatulence—Mycophenolic acid—systemic scleroderma	0.000625	0.00322	CcSEcCtD
Zileuton—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.000625	0.00321	CcSEcCtD
Zileuton—Conjunctivitis—Mycophenolate mofetil—systemic scleroderma	0.000623	0.0032	CcSEcCtD
Zileuton—Urinary tract infection—Mycophenolate mofetil—systemic scleroderma	0.000623	0.0032	CcSEcCtD
Zileuton—Tension—Mycophenolic acid—systemic scleroderma	0.000623	0.0032	CcSEcCtD
Zileuton—Ill-defined disorder—Leflunomide—systemic scleroderma	0.000617	0.00317	CcSEcCtD
Zileuton—Nervousness—Mycophenolic acid—systemic scleroderma	0.000616	0.00317	CcSEcCtD
Zileuton—Pruritus—Pentoxifylline—systemic scleroderma	0.000615	0.00316	CcSEcCtD
Zileuton—Vaginal infection—Methotrexate—systemic scleroderma	0.000613	0.00315	CcSEcCtD
Zileuton—Sinusitis—Mycophenolate mofetil—systemic scleroderma	0.000601	0.00309	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.0006	0.00309	CcSEcCtD
Zileuton—Malaise—Leflunomide—systemic scleroderma	0.0006	0.00308	CcSEcCtD
Zileuton—Myalgia—Azathioprine—systemic scleroderma	0.0006	0.00308	CcSEcCtD
Zileuton—Arthralgia—Azathioprine—systemic scleroderma	0.0006	0.00308	CcSEcCtD
Zileuton—Insomnia—Captopril—systemic scleroderma	0.000596	0.00306	CcSEcCtD
Zileuton—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000595	0.00306	CcSEcCtD
Zileuton—Body temperature increased—Mometasone—systemic scleroderma	0.000593	0.00305	CcSEcCtD
Zileuton—Discomfort—Azathioprine—systemic scleroderma	0.000593	0.00305	CcSEcCtD
Zileuton—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.000589	0.00303	CcSEcCtD
Zileuton—Somnolence—Captopril—systemic scleroderma	0.000586	0.00301	CcSEcCtD
Zileuton—Dyspepsia—Captopril—systemic scleroderma	0.00058	0.00298	CcSEcCtD
Zileuton—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.000575	0.00296	CcSEcCtD
Zileuton—Dizziness—Pentoxifylline—systemic scleroderma	0.000575	0.00296	CcSEcCtD
Zileuton—Malaise—Mycophenolic acid—systemic scleroderma	0.000572	0.00294	CcSEcCtD
Zileuton—Myalgia—Leflunomide—systemic scleroderma	0.000566	0.00291	CcSEcCtD
Zileuton—Arthralgia—Leflunomide—systemic scleroderma	0.000566	0.00291	CcSEcCtD
Zileuton—Chest pain—Leflunomide—systemic scleroderma	0.000566	0.00291	CcSEcCtD
Zileuton—CYP3A4—digestive system—systemic scleroderma	0.000564	0.0105	CbGeAlD
Zileuton—PTGS1—lung—systemic scleroderma	0.000564	0.0105	CbGeAlD
Zileuton—Constipation—Captopril—systemic scleroderma	0.000563	0.0029	CcSEcCtD
Zileuton—Flatulence—Lisinopril—systemic scleroderma	0.000563	0.0029	CcSEcCtD
Zileuton—Tension—Lisinopril—systemic scleroderma	0.000561	0.00288	CcSEcCtD
Zileuton—Discomfort—Leflunomide—systemic scleroderma	0.00056	0.00288	CcSEcCtD
Zileuton—Nervousness—Lisinopril—systemic scleroderma	0.000555	0.00285	CcSEcCtD
Zileuton—Vomiting—Pentoxifylline—systemic scleroderma	0.000553	0.00284	CcSEcCtD
Zileuton—Lymphadenopathy—Methotrexate—systemic scleroderma	0.000552	0.00284	CcSEcCtD
Zileuton—Rash—Pentoxifylline—systemic scleroderma	0.000548	0.00282	CcSEcCtD
Zileuton—Dermatitis—Pentoxifylline—systemic scleroderma	0.000548	0.00282	CcSEcCtD
Zileuton—Headache—Pentoxifylline—systemic scleroderma	0.000545	0.0028	CcSEcCtD
Zileuton—Feeling abnormal—Captopril—systemic scleroderma	0.000543	0.00279	CcSEcCtD
Zileuton—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00054	0.00278	CcSEcCtD
Zileuton—Myalgia—Mycophenolic acid—systemic scleroderma	0.00054	0.00278	CcSEcCtD
Zileuton—Chest pain—Mycophenolic acid—systemic scleroderma	0.00054	0.00278	CcSEcCtD
Zileuton—Discomfort—Mycophenolic acid—systemic scleroderma	0.000534	0.00274	CcSEcCtD
Zileuton—Pruritus—Mometasone—systemic scleroderma	0.000531	0.00273	CcSEcCtD
Zileuton—Ill-defined disorder—Lisinopril—systemic scleroderma	0.00053	0.00273	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000524	0.00269	CcSEcCtD
Zileuton—Body temperature increased—Captopril—systemic scleroderma	0.000521	0.00268	CcSEcCtD
Zileuton—Nausea—Pentoxifylline—systemic scleroderma	0.000516	0.00265	CcSEcCtD
Zileuton—Malaise—Lisinopril—systemic scleroderma	0.000516	0.00265	CcSEcCtD
Zileuton—Diarrhoea—Mometasone—systemic scleroderma	0.000513	0.00264	CcSEcCtD
Zileuton—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000496	0.00255	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000495	0.00254	CcSEcCtD
Zileuton—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000494	0.00254	CcSEcCtD
Zileuton—Tension—Mycophenolate mofetil—systemic scleroderma	0.000492	0.00253	CcSEcCtD
Zileuton—Insomnia—Leflunomide—systemic scleroderma	0.000491	0.00252	CcSEcCtD
Zileuton—Myalgia—Lisinopril—systemic scleroderma	0.000487	0.0025	CcSEcCtD
Zileuton—Arthralgia—Lisinopril—systemic scleroderma	0.000487	0.0025	CcSEcCtD
Zileuton—Chest pain—Lisinopril—systemic scleroderma	0.000487	0.0025	CcSEcCtD
Zileuton—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000486	0.0025	CcSEcCtD
Zileuton—Discomfort—Lisinopril—systemic scleroderma	0.000481	0.00247	CcSEcCtD
Zileuton—Dyspepsia—Leflunomide—systemic scleroderma	0.000478	0.00246	CcSEcCtD
Zileuton—Vomiting—Mometasone—systemic scleroderma	0.000477	0.00245	CcSEcCtD
Zileuton—Feeling abnormal—Azathioprine—systemic scleroderma	0.000474	0.00244	CcSEcCtD
Zileuton—Rash—Mometasone—systemic scleroderma	0.000473	0.00243	CcSEcCtD
Zileuton—Dermatitis—Mometasone—systemic scleroderma	0.000473	0.00243	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000472	0.00243	CcSEcCtD
Zileuton—Headache—Mometasone—systemic scleroderma	0.00047	0.00242	CcSEcCtD
Zileuton—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000469	0.00241	CcSEcCtD
Zileuton—Insomnia—Mycophenolic acid—systemic scleroderma	0.000468	0.00241	CcSEcCtD
Zileuton—Pruritus—Captopril—systemic scleroderma	0.000466	0.0024	CcSEcCtD
Zileuton—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000465	0.00239	CcSEcCtD
Zileuton—Pain—Leflunomide—systemic scleroderma	0.000464	0.00239	CcSEcCtD
Zileuton—Constipation—Leflunomide—systemic scleroderma	0.000464	0.00239	CcSEcCtD
Zileuton—Somnolence—Mycophenolic acid—systemic scleroderma	0.00046	0.00237	CcSEcCtD
Zileuton—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000456	0.00234	CcSEcCtD
Zileuton—Body temperature increased—Azathioprine—systemic scleroderma	0.000455	0.00234	CcSEcCtD
Zileuton—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000452	0.00232	CcSEcCtD
Zileuton—Diarrhoea—Captopril—systemic scleroderma	0.000451	0.00232	CcSEcCtD
Zileuton—Feeling abnormal—Leflunomide—systemic scleroderma	0.000447	0.0023	CcSEcCtD
Zileuton—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000447	0.0023	CcSEcCtD
Zileuton—Nausea—Mometasone—systemic scleroderma	0.000446	0.00229	CcSEcCtD
Zileuton—Constipation—Mycophenolic acid—systemic scleroderma	0.000443	0.00228	CcSEcCtD
Zileuton—Pain—Mycophenolic acid—systemic scleroderma	0.000443	0.00228	CcSEcCtD
Zileuton—Dizziness—Captopril—systemic scleroderma	0.000436	0.00224	CcSEcCtD
Zileuton—Urticaria—Leflunomide—systemic scleroderma	0.000431	0.00222	CcSEcCtD
Zileuton—Body temperature increased—Leflunomide—systemic scleroderma	0.000429	0.00221	CcSEcCtD
Zileuton—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000427	0.00219	CcSEcCtD
Zileuton—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000426	0.00219	CcSEcCtD
Zileuton—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000426	0.00219	CcSEcCtD
Zileuton—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000426	0.00219	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000425	0.00219	CcSEcCtD
Zileuton—Hypersensitivity—Azathioprine—systemic scleroderma	0.000424	0.00218	CcSEcCtD
Zileuton—Insomnia—Lisinopril—systemic scleroderma	0.000422	0.00217	CcSEcCtD
Zileuton—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000421	0.00217	CcSEcCtD
Zileuton—Vomiting—Captopril—systemic scleroderma	0.000419	0.00215	CcSEcCtD
Zileuton—Rash—Captopril—systemic scleroderma	0.000415	0.00214	CcSEcCtD
Zileuton—Dermatitis—Captopril—systemic scleroderma	0.000415	0.00213	CcSEcCtD
Zileuton—Somnolence—Lisinopril—systemic scleroderma	0.000415	0.00213	CcSEcCtD
Zileuton—Headache—Captopril—systemic scleroderma	0.000413	0.00212	CcSEcCtD
Zileuton—Dyspepsia—Lisinopril—systemic scleroderma	0.000411	0.00211	CcSEcCtD
Zileuton—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000409	0.00211	CcSEcCtD
Zileuton—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000403	0.00207	CcSEcCtD
Zileuton—Hypersensitivity—Leflunomide—systemic scleroderma	0.0004	0.00206	CcSEcCtD
Zileuton—Pain—Lisinopril—systemic scleroderma	0.000399	0.00205	CcSEcCtD
Zileuton—Constipation—Lisinopril—systemic scleroderma	0.000399	0.00205	CcSEcCtD
Zileuton—Diarrhoea—Azathioprine—systemic scleroderma	0.000393	0.00202	CcSEcCtD
Zileuton—Nausea—Captopril—systemic scleroderma	0.000391	0.00201	CcSEcCtD
Zileuton—Feeling abnormal—Lisinopril—systemic scleroderma	0.000384	0.00198	CcSEcCtD
Zileuton—Pruritus—Leflunomide—systemic scleroderma	0.000384	0.00198	CcSEcCtD
Zileuton—Dizziness—Azathioprine—systemic scleroderma	0.00038	0.00195	CcSEcCtD
Zileuton—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000378	0.00195	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000372	0.00191	CcSEcCtD
Zileuton—Diarrhoea—Leflunomide—systemic scleroderma	0.000372	0.00191	CcSEcCtD
Zileuton—Urticaria—Lisinopril—systemic scleroderma	0.000371	0.00191	CcSEcCtD
Zileuton—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00037	0.0019	CcSEcCtD
Zileuton—Body temperature increased—Lisinopril—systemic scleroderma	0.000369	0.0019	CcSEcCtD
Zileuton—Pruritus—Mycophenolic acid—systemic scleroderma	0.000366	0.00188	CcSEcCtD
Zileuton—Vomiting—Azathioprine—systemic scleroderma	0.000366	0.00188	CcSEcCtD
Zileuton—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000363	0.00187	CcSEcCtD
Zileuton—Rash—Azathioprine—systemic scleroderma	0.000363	0.00186	CcSEcCtD
Zileuton—Dermatitis—Azathioprine—systemic scleroderma	0.000362	0.00186	CcSEcCtD
Zileuton—Headache—Azathioprine—systemic scleroderma	0.00036	0.00185	CcSEcCtD
Zileuton—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00036	0.00185	CcSEcCtD
Zileuton—Dizziness—Leflunomide—systemic scleroderma	0.000359	0.00185	CcSEcCtD
Zileuton—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000354	0.00182	CcSEcCtD
Zileuton—Conjunctivitis—Methotrexate—systemic scleroderma	0.000353	0.00181	CcSEcCtD
Zileuton—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000353	0.00181	CcSEcCtD
Zileuton—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00035	0.0018	CcSEcCtD
Zileuton—Pain—Mycophenolate mofetil—systemic scleroderma	0.00035	0.0018	CcSEcCtD
Zileuton—Vomiting—Leflunomide—systemic scleroderma	0.000345	0.00177	CcSEcCtD
Zileuton—Hypersensitivity—Lisinopril—systemic scleroderma	0.000344	0.00177	CcSEcCtD
Zileuton—Dizziness—Mycophenolic acid—systemic scleroderma	0.000343	0.00176	CcSEcCtD
Zileuton—Rash—Leflunomide—systemic scleroderma	0.000342	0.00176	CcSEcCtD
Zileuton—Dermatitis—Leflunomide—systemic scleroderma	0.000342	0.00176	CcSEcCtD
Zileuton—Nausea—Azathioprine—systemic scleroderma	0.000342	0.00176	CcSEcCtD
Zileuton—Headache—Leflunomide—systemic scleroderma	0.00034	0.00175	CcSEcCtD
Zileuton—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000337	0.00173	CcSEcCtD
Zileuton—Pruritus—Lisinopril—systemic scleroderma	0.00033	0.0017	CcSEcCtD
Zileuton—Vomiting—Mycophenolic acid—systemic scleroderma	0.000329	0.00169	CcSEcCtD
Zileuton—Rash—Mycophenolic acid—systemic scleroderma	0.000327	0.00168	CcSEcCtD
Zileuton—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000326	0.00168	CcSEcCtD
Zileuton—Hepatitis—Methotrexate—systemic scleroderma	0.000326	0.00168	CcSEcCtD
Zileuton—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000325	0.00167	CcSEcCtD
Zileuton—Headache—Mycophenolic acid—systemic scleroderma	0.000324	0.00167	CcSEcCtD
Zileuton—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000323	0.00166	CcSEcCtD
Zileuton—Nausea—Leflunomide—systemic scleroderma	0.000323	0.00166	CcSEcCtD
Zileuton—Diarrhoea—Lisinopril—systemic scleroderma	0.000319	0.00164	CcSEcCtD
Zileuton—Ill-defined disorder—Prednisone—systemic scleroderma	0.000315	0.00162	CcSEcCtD
Zileuton—Dizziness—Lisinopril—systemic scleroderma	0.000309	0.00159	CcSEcCtD
Zileuton—Nausea—Mycophenolic acid—systemic scleroderma	0.000308	0.00158	CcSEcCtD
Zileuton—Malaise—Prednisone—systemic scleroderma	0.000306	0.00157	CcSEcCtD
Zileuton—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000301	0.00155	CcSEcCtD
Zileuton—Vomiting—Lisinopril—systemic scleroderma	0.000297	0.00153	CcSEcCtD
Zileuton—Rash—Lisinopril—systemic scleroderma	0.000294	0.00151	CcSEcCtD
Zileuton—Dermatitis—Lisinopril—systemic scleroderma	0.000294	0.00151	CcSEcCtD
Zileuton—Headache—Lisinopril—systemic scleroderma	0.000292	0.0015	CcSEcCtD
Zileuton—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000289	0.00149	CcSEcCtD
Zileuton—Myalgia—Prednisone—systemic scleroderma	0.000289	0.00149	CcSEcCtD
Zileuton—Arthralgia—Prednisone—systemic scleroderma	0.000289	0.00149	CcSEcCtD
Zileuton—Discomfort—Prednisone—systemic scleroderma	0.000286	0.00147	CcSEcCtD
Zileuton—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00028	0.00144	CcSEcCtD
Zileuton—Nausea—Lisinopril—systemic scleroderma	0.000277	0.00142	CcSEcCtD
Zileuton—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00027	0.00139	CcSEcCtD
Zileuton—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000263	0.00135	CcSEcCtD
Zileuton—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00026	0.00134	CcSEcCtD
Zileuton—Rash—Mycophenolate mofetil—systemic scleroderma	0.000258	0.00133	CcSEcCtD
Zileuton—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000258	0.00132	CcSEcCtD
Zileuton—Headache—Mycophenolate mofetil—systemic scleroderma	0.000256	0.00132	CcSEcCtD
Zileuton—Malaise—Methotrexate—systemic scleroderma	0.000256	0.00132	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000252	0.0013	CcSEcCtD
Zileuton—Insomnia—Prednisone—systemic scleroderma	0.000251	0.00129	CcSEcCtD
Zileuton—Dyspepsia—Prednisone—systemic scleroderma	0.000244	0.00125	CcSEcCtD
Zileuton—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000243	0.00125	CcSEcCtD
Zileuton—Chest pain—Methotrexate—systemic scleroderma	0.000242	0.00124	CcSEcCtD
Zileuton—Myalgia—Methotrexate—systemic scleroderma	0.000242	0.00124	CcSEcCtD
Zileuton—Arthralgia—Methotrexate—systemic scleroderma	0.000242	0.00124	CcSEcCtD
Zileuton—Discomfort—Methotrexate—systemic scleroderma	0.000239	0.00123	CcSEcCtD
Zileuton—Constipation—Prednisone—systemic scleroderma	0.000237	0.00122	CcSEcCtD
Zileuton—Feeling abnormal—Prednisone—systemic scleroderma	0.000228	0.00117	CcSEcCtD
Zileuton—Urticaria—Prednisone—systemic scleroderma	0.00022	0.00113	CcSEcCtD
Zileuton—Body temperature increased—Prednisone—systemic scleroderma	0.000219	0.00113	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000211	0.00108	CcSEcCtD
Zileuton—Insomnia—Methotrexate—systemic scleroderma	0.000209	0.00108	CcSEcCtD
Zileuton—Somnolence—Methotrexate—systemic scleroderma	0.000206	0.00106	CcSEcCtD
Zileuton—Hypersensitivity—Prednisone—systemic scleroderma	0.000204	0.00105	CcSEcCtD
Zileuton—Dyspepsia—Methotrexate—systemic scleroderma	0.000204	0.00105	CcSEcCtD
Zileuton—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.0002	0.00103	CcSEcCtD
Zileuton—Pain—Methotrexate—systemic scleroderma	0.000198	0.00102	CcSEcCtD
Zileuton—Pruritus—Prednisone—systemic scleroderma	0.000196	0.00101	CcSEcCtD
Zileuton—Feeling abnormal—Methotrexate—systemic scleroderma	0.000191	0.000981	CcSEcCtD
Zileuton—Diarrhoea—Prednisone—systemic scleroderma	0.00019	0.000975	CcSEcCtD
Zileuton—Urticaria—Methotrexate—systemic scleroderma	0.000184	0.000946	CcSEcCtD
Zileuton—Dizziness—Prednisone—systemic scleroderma	0.000183	0.000942	CcSEcCtD
Zileuton—Body temperature increased—Methotrexate—systemic scleroderma	0.000183	0.000941	CcSEcCtD
Zileuton—Vomiting—Prednisone—systemic scleroderma	0.000176	0.000906	CcSEcCtD
Zileuton—Rash—Prednisone—systemic scleroderma	0.000175	0.000898	CcSEcCtD
Zileuton—Dermatitis—Prednisone—systemic scleroderma	0.000175	0.000897	CcSEcCtD
Zileuton—Headache—Prednisone—systemic scleroderma	0.000174	0.000892	CcSEcCtD
Zileuton—Hypersensitivity—Methotrexate—systemic scleroderma	0.000171	0.000877	CcSEcCtD
Zileuton—Nausea—Prednisone—systemic scleroderma	0.000165	0.000846	CcSEcCtD
Zileuton—Pruritus—Methotrexate—systemic scleroderma	0.000164	0.000842	CcSEcCtD
Zileuton—Diarrhoea—Methotrexate—systemic scleroderma	0.000158	0.000815	CcSEcCtD
Zileuton—Dizziness—Methotrexate—systemic scleroderma	0.000153	0.000787	CcSEcCtD
Zileuton—Vomiting—Methotrexate—systemic scleroderma	0.000147	0.000757	CcSEcCtD
Zileuton—Rash—Methotrexate—systemic scleroderma	0.000146	0.000751	CcSEcCtD
Zileuton—Dermatitis—Methotrexate—systemic scleroderma	0.000146	0.00075	CcSEcCtD
Zileuton—Headache—Methotrexate—systemic scleroderma	0.000145	0.000746	CcSEcCtD
Zileuton—Nausea—Methotrexate—systemic scleroderma	0.000138	0.000707	CcSEcCtD
